Arif Wibowo

Arif Wibowo is a Senior Scientist II at AbbVie, a position held since July 2021. Prior to this role, Wibowo was a Scientist at Regeneron Pharmaceuticals, Inc. from October 2018 to June 2021 and a Post Doctoral Research Fellow at Stanford University from September 2013 to September 2018, focusing on protein mimetics, antibody conjugation, HIV vaccine development, and advanced imaging techniques. Wibowo also served as a Graduate Research Assistant at the California Institute of Technology from 2006 to 2013, and as an Undergraduate Research Assistant at UC Berkeley from 2004 to 2006, contributing to cancer therapeutic research. Wibowo earned a PhD in Chemistry/Chemical Biology from Caltech and a BSc in Chemistry/Chemical Biology from UC Berkeley.